Skip to main content
. 2018 Sep 24;62(10):e00940-18. doi: 10.1128/AAC.00940-18

TABLE 1.

Final population pharmacokinetic estimates and bootstrap results for ceftriaxone plasma concentrations and dried blood spot-derived plasma concentration for 10 pediatric patients

Parameterb Plasma parameter
Relative difference in DBS parameter
P valuea
Estimate 95% CIc Estimate 95% CI
Objective function value −143.299 −260.652 to −77.903
Structural model parameters
    CL (liters/h/70 kg) 1.05 0.54 to 1.67 1.01 0.9 to 1.17 0.856
    VC (liters/70 kg) 5.89 4.29 to 16.82 1.01 0.69 to 1.25 0.706
    Q (liters/h/70 kg) 7.38 1.07 to 9.29 0.829 0.63 to 3.49 0.726
    VP (liters/70 kg) 10.4 5.21 to 16.2 1.02 0.83 to 1.48 0.542
Variable model parameters [shrinkage %]
    IIV in CL 68 17 to 102 1.06 0.8 to 1.2 0.618
    IIV in VC 80 5 to 124 0.964 0.67 to 1.3 0.514
    RV 25 12 to 34 1.12 0.96 to 1.19 0.23
a

P value obtained from likelihood ratio testing.

b

CL (clearance), VC (central volume of distribution), Q (intercompartmental clearance), VP (peripheral volume of distribution), IIV (interindividual variability), and RV (residual variability). IIV presented as 100%×variance estimate.

c

CI, confidence interval.